24 results
424B5
GMDAQ
Gamida Cell Ltd
20 Apr 23
Prospectus supplement for primary offering
5:27pm
, acceptance by the medical community, and patient access, drug pricing, and reimbursement. The number of patients in our targeted commercial markets
424B5
us74ecy3kw9lhb8jg
19 Apr 23
Prospectus supplement for primary offering
6:46am
10-Q
z9zwj2xfv46ad
12 May 22
Quarterly report
7:42am
10-K
7mmi9qm1uq9
24 Mar 22
Annual report
7:30am
6-K
EX-99.2
w159 imdv5hno99x2ld7
9 Dec 20
Report of Foreign Private Issuer
3:37pm
424B4
c7vrmvggadq
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
9pfipt
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
yvupx5 vaw404
24 Jun 19
Registration statement (foreign)
4:04pm
20-F
nt9kqs
25 Feb 19
Annual report (foreign)
5:08pm
DRS
jc6w hahopt
15 Feb 19
Draft registration statement
12:00am
424B4
v3wxjcenl6c
30 Oct 18
Prospectus supplement with pricing info
8:35am